Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
TRD
Name:
T cell receptor delta locus
Location:
14q11.2
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT04199143 | Brain Reactivity to Nitrous Oxyde in Depression an MRI and Ultrasound Study PROTOBRAIN Pilote | View | |
| NCT00229398 | Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder | View | |
| NCT00220480 | A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression | View | |
| NCT00294944 | The Effectiveness of Idazoxan in Treating TRD | View | |
| NCT00402220 | A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression | View | |
| NCT00305565 | Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses | View | |
| NCT01304147 | Intranasal Ketamine in Treatment-Resistant Depression | View | |
| NCT01426516 | Pharmacogenomics for Antidepressant Guidance and Education 1 PAGE-1_AG1 | View | |
| NCT01687478 | A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression | View | |
| NCT04239651 | rTMS With and Without iCBT For the Treatment of Resistant Depression TRD | View | |
| NCT01945047 | Action of Ketamine in Treatment-Resistant Depression | View | |
| NCT02122562 | Ketamine Alcohol in Treatment-Resistant Depression | View | |
| NCT02497287 | A Long-term Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression | View | |
| NCT02810717 | Effects of TBS on 5-HT1A Receptor Binding | View | |
| NCT04663321 | Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression TRD MK-1942-006 | View | |
| NCT03977038 | Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression | View | |
| NCT02960763 | Optimizing Outcomes of Treatment-Resistant Depression in Older Adults | View | |
| NCT03113968 | ELEKT-D Electroconvulsive Therapy ECT vs Ketamine in Patients With Treatment Resistant Depression TRD | View | |
| NCT03257397 | TBS in Major Depression | View | |
| NCT03373253 | Treatment-Resistant Depression Cohort in Europe | View | |
| NCT03537794 | Characterizing Dopamine Receptor Binding in Treatment Resistant Depression | View | |
| NCT05973851 | The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment | View | |
| NCT03872492 | Major Depressive Disorder Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale | View | |
| NCT03947827 | Minocycline as Adjunctive Treatment for Treatment Resistant Depression | View | |
| NCT03965858 | Efficacy Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression | View | |
| NCT05887310 | In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells | View | |
| NCT05390086 | Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders | View | |
| NCT05418894 | Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing | View | |
| NCT04936126 | Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression | View | |
| NCT05004896 | Ketamine for Treatment-Resistant Bipolar Disorder | View | |
| NCT05136027 | TReAtment With CombinedExercise in Patients With Resistant Major Depression | View | |
| NCT05144789 | Personalized Therapeutic Neuromodulation for Anhedonic Depression | View | |
| NCT05172271 | Transcranial Electric Stimulation Therapy TEST for Treatment Resistant Depression TRD | View | |
| NCT06404320 | Physical Activity Program for TRD | View | |
| NCT05900271 | Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS | View | |
| NCT05952674 | Treatment Resistant Depression and Vagus Nerve Stimulation | View | |
| NCT05339074 | Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression | View | |
| NCT05393622 | Brain Stimulation for Severe Depression | View | |
| NCT05422417 | Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression | View | |
| NCT05625555 | Predictors of Intravenous Ketamine Response in TRD | View | |
| NCT02691520 | Epidemiology of Treatment Resistant Depression in Taiwan | View | |
| NCT05773755 | DBS for TRD with the Medtronic Percept PC | View | |
| NCT05798143 | Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression | View | |
| NCT05871372 | Intracranial Investigation of Neural Circuity Underlying Human Mood | View | |
| NCT06044324 | Positron Emission Tomography in Transcranial Magnetic Stimulation Intervention for Treatment-resistant Depression | View | |
| NCT01204918 | Efficacy and Tolerability of Riluzole in Treatment Resistant Depression | View | |
| NCT06396312 | Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression | View | |
| NCT02918318 | A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression | View | |
| NCT05066672 | Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression | View | |
| NCT04106466 | DBS for TRD With the Medtronic Summit RCS | View | |
| NCT00093847 | Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors SSRIs in Treatment-Resistant Depression | View | |
| NCT01179009 | Treatment Resistant Depression Pilot | View | |
| NCT01282632 | Risperidone vs Olanzapine as add-on Treatment in Treatment Resistant Depression | View | |
| NCT03775200 | The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression | View | |
| NCT01312207 | Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy | View | |
| NCT00441636 | Treatment Resistant Depression and Obstructive Sleep Apnea Effect of Continuous Positive Airway Pressure CPAP | View | |
| NCT01920555 | Double-Blind Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression TRD | View | |
| NCT00533832 | Pivotal Trial D02 of Vagus Nerve Stimulation VNS for Treatment-Resistant Depression TRD | View | |
| NCT04476446 | An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression TRD Who do Not Have Other Treatment Alternatives | View | |
| NCT04480918 | University of Iowa Interventional Psychiatry Service Patient Registry | View | |
| NCT00646087 | Ketamine Frequency Treatment for Major Depressive Disorder | View | |
| NCT01582945 | Ketamine Infusion for Treatment-resistant Major Depressive Disorder | View | |
| NCT01589718 | A Study of the Safety Tolerability and Efficacy of IVT Pre-op 03mg Pegaptanib Sodium Versus Sham for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy | View | |
| NCT01613820 | Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder | View | |
| NCT01728038 | Exploring a Cessation Intervention for Smokers | View | |
| NCT02741791 | A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder | View | |
| NCT02154984 | Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants | View | |
| NCT04753385 | The RECOVER sUb-study Which Leverages quaNtitative and Credible Research tOols From Verily Will providE Assessment measuRes for Depressive Episodes | View | |
| NCT01246908 | Efficacy Safety and Tolerability of CX157 in Treatment Resistant Depression | View | |
| NCT01270542 | Avastin for PDR Proliferative Diabetic Retinopathy | View | |
| NCT01309945 | Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression | View | |
| NCT01369095 | Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression | View | |
| NCT01383811 | Exercise in Treatment Resistant Depression TRD A Feasibility Study | View | |
| NCT01403441 | Radiosurgical Neuromodulation for Refractory Depression | View | |
| NCT01407575 | Buprenorphine for Treatment Resistant Depression | View | |
| NCT01798407 | DBS of the Lateral Habenula in Treatment-Resistant Depression | View | |
| NCT04924257 | ECT vs Esketamine | View | |
| NCT04979910 | Targeting IL-17A for Treatment-Resistant Depression | View | |
| NCT04971291 | An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients | View | |
| NCT01627782 | A Study of Ketamine in Patients With Treatment-resistant Depression | View | |
| NCT04999553 | Left vs Right Non-Inferiority Trial | View | |
| NCT05008198 | Assessing an EEG Biomarker of Response to TMS for Major Depression | View | |
| NCT02971150 | Treatment Resistant Depression and Insomnia in Older Veterans | View | |
| NCT05045378 | Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression | View | |
| NCT01801319 | A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression | View | |
| NCT03113890 | McLean and Genomind Prospective Study | View | |
| NCT05137938 | Intranasal Ketamine in Ultra-REsistant Depression SURE-ECT Non Responders | View | |
| NCT03434041 | A Study to Evaluate the Efficacy Pharmacokinetics Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression | View | |
| NCT03320304 | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression | View | |
| NCT01880593 | Ketamine Plus Lithium in Treatment-Resistant Depression | View | |
| NCT01913535 | Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression | View | |
| NCT01976923 | Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy | View | |
| NCT01984710 | Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PCS | View | |
| NCT03360942 | Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression | View | |
| NCT03207282 | Treatment Resistant Depression in America Latina | View | |
| NCT02046330 | Deep Brain Stimulation DBS Therapy for Treatment Resistant Depression | View | |
| NCT03240692 | Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression OL Cohort | View | |
| NCT05377177 | Cortical Inhibition As a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI | View | |
| NCT05414422 | A Randomized Placebo-Controlled Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD | View | |
| NCT05464264 | Auditory MMN EEG in TRD in Response to Ketamine | View | |
| NCT05480761 | 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low Moderate and Normal Sucrase Levels | View | |
| NCT05531591 | RCT of Brain Longitudinal Biomarker Study OPT-Neuro RCT | View | |
| NCT05577247 | Belief Updating in Treatment Resistant Depression | View | |
| NCT02417064 | A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression | View | |
| NCT02452892 | Low Field Magnetic Stimulation LFMS in Subjects With Treatment-Resistant Depression TRD | View | |
| NCT02456948 | Adjunct Minocyline in Treatment-resistant Depression | View | |
| NCT05624268 | Efficacy Safety and Tolerability of COMP360 in Participants With TRD | View | |
| NCT03591939 | T-regulatory Cells in Diabetic Type Two Nephropathy | View | |
| NCT02610712 | Clinical Trial of the Use of Ketamine in Treatment Resistant Depression | View | |
| NCT05722028 | Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device TruClear System Without Anesthesia | View | |
| NCT05739539 | Assessment of Retinal Vascular Changes With and Without ILM Peeling in Diabetic Vitrectomy Using OCT-A | View | |
| NCT04216095 | Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder | View | |
| NCT05777876 | Early Identification of TRD and Construction and Clinical Validation of NTBS Precision Technology | View | |
| NCT02757521 | Nitrous TRD Bipolar Depression | View | |
| NCT02788487 | Randomized Cross-over TRD and CPAP for OSA | View | |
| NCT02782104 | A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression | View | |
| NCT03852160 | A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression | View | |
| NCT02882711 | The UTHealth Ketamine Project | View | |
| NCT02935595 | Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients | View | |
| NCT02977299 | Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD | View | |
| NCT04469322 | Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression | View | |
| NCT05948839 | pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression | View | |
| NCT03004521 | Lithium Versus Quetiapine in Treatment Resistant Depression | View | |
| NCT04338321 | A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release Both in Combination With a Selective Serotonin Reuptake InhibitorSerotonin-Norepinephrine Reuptake Inhibitor in Participants With Treatment Resistant Major Depressive Disorder | View | |
| NCT03068715 | Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression SAINT-TRD | View | |
| NCT03109002 | An Epidemiology Study of Treatment Resistant Depression in the United States US | View | |
| NCT03109717 | Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression | View | |
| NCT06003309 | Frequency and E-field Enhancement of ITBS for Depression FREED | View | |
| NCT03134066 | Neurocognitive Features of Patients With Treatment-Resistant Depression | View | |
| NCT03149991 | A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression TRD | View | |
| NCT02383693 | Maintenance rTMS for Treatment-resistant Depression TRD a One-year Double Blind Controlled Study | View | |
| NCT03175887 | Investigational TMS Treatment for Depression | View | |
| NCT04530942 | The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression | View | |
| NCT04531423 | PKC as Serum Biomarkers for Depression | View | |
| NCT06110507 | Chronic Anergic-anhedonic Depression Open Trial | View | |
| NCT04613453 | Reducing Adolescent Suicide Risk Safety Efficacy and Connectome Phenotypes of Intravenous Ketamine | View | |
| NCT06166082 | Stanford Neuromodulation Therapy SNT for the Treatment-Resistant Depression | View | |
| NCT03437928 | Deep Brain Stimulation DBS for Depression Using Directional Current Steering and Individualized Network Targeting | View | |
| NCT04657107 | The Efficacy and Safety of S-ketamine in Elective Cesarean Section | View | |
| NCT04670081 | Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression | View | |
| NCT03564067 | MARt-Depression Trial | View | |
| NCT03606395 | Safety Tolerability PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression | View | |
| NCT03626337 | Thiamine Responsive Disorders TRD Among Infants in Lao PDR | View | |
| NCT06323486 | Accelerated Bilateral Sequential Theta Burst Stimulation in Older Adults With Treatment-resistant Depression | View | |
| NCT03667872 | Efficacy and Safety of DBS in Patients With Treatment-Resistant Depression | View | |
| NCT06341426 | Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression Comparing One Versus Two Doses of Psilocybin | View | |
| NCT06391723 | Clinical Cognitive and Neural Effects of Potentiation of ECT by rTMS in Treatment-Resistant Depression | View | |
| NCT06399406 | Mindfulness Engaged Neurostimulation for Depression | View | |
| NCT03829579 | Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression TRD | View | |
| NCT03887715 | A Prospective Multi-center Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression | View | |
| NCT04009928 | Deep Brain Stimulation for Treatment Resistant Depression | View | |
| NCT05028738 | Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and Anxiety | View | |
| NCT04101474 | Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality | View | |
| NCT05220410 | The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation | View | |
| NCT05710887 | N2O for Acute Suicidality and Depression in the ED | View | |
| NCT05711940 | Efficacy Safety and Tolerability of Two Administrations of COMP360 in Participants With TRD | View | |
| NCT04352621 | Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder TRD | View | |
| NCT04433858 | An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression P-TRD | View | |
| NCT04504175 | Ketamine for Older Adults Pilot | View | |
| NCT04519957 | Long Term Follow Up Study to COMP 001 And COMP 003 Trials P-TRD LTFU | View | |
| NCT05800730 | Westlake Precision Nutrition Study 2 WePrecision2 | View | |
| NCT05800860 | A Trial of GH001 in Patients With Treatment-resistant Depression | View | |
| NCT04599855 | A Study of Esketamine Nasal Spray Administered as Monotherapy in Adult Participants With Treatment-resistant Depression | View | |
| NCT04608396 | Mechanistic Evaluation of Response in TRD MERIT | View | |
| NCT04634669 | Open-Label Safety Study of AXS-05 in Subjects With TRD EVOLVE | View | |
| NCT04680910 | Slow Wave Induction by Propofol to Eliminate Depression SWIPED | View | |
| NCT04698603 | Clinical Study of GH001 in Depression | View | |
| NCT04701866 | Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression | View | |
| NCT05870501 | Synaptic Imaging and Network Activity in Treatment Resistant Depression | View | |
| NCT05870540 | BPL-003 Efficacy and Safety in Treatment Resistant Depression | View | |
| NCT06331572 | Exploring Blood Plasma Metabolomics Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression | View | |
| NCT04805879 | The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder | View | |
| NCT06112652 | Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique | View | |
| NCT05008939 | Sevoflurane for Treatment-Resistant Depression | View | |
| NCT01882829 | Nuedexta in Treatment-Resistant Major Depression | View | |
| NCT05139862 | Neurocardiac Predictors of Treatment Response to rTMS in Depression | View | |
| NCT01898429 | Deep Brain Stimulation DBS for Treatment-Resistant Depression TRD | View | |
| NCT05196971 | A Study To Evaluate The Safety Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression | View | |
| NCT06542900 | Efficacy of Deep Brain StimulationDBS for Treatment-Resistant DepressionTRD | View | |
| NCT05324735 | Pentoxifylline for Treatment of Resistant Major Depression | View | |
| NCT06650800 | Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression | View | |
| NCT05383313 | Psilocybin Versus Ketamine in Treatment-Resistant Depression | View | |
| NCT06560073 | Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries | View | |
| NCT06512220 | Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression SYNVEST | View | |
| NCT06620276 | ACT_for Alcohol Use Disorder and Depression | View | |
| NCT00664976 | Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy | View | |
| NCT01973478 | Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression | View | |
| NCT06524830 | A Study to Assess the Efficacy Safety and Tolerability of VLS-01 Buccal Film Compared to Placebo in Patients With Treatment Resistant Depression | View | |
| NCT01983904 | DBS for Treatment Resistant Depression | View | |
| NCT01998958 | A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression | View | |
| NCT00789854 | Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients | View | |
| NCT05725239 | taVNS or TMS or Both for Depression | View | |
| NCT00955955 | Study of 6S-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder | View | |
| NCT05905705 | Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy | View | |
| NCT05902312 | Repetitive Versus Deep Transcranial Magnetic Stimulation for Major Depression | View | |
| NCT00548964 | Continuation Ketamine in Major Depression | View | |
| NCT06052137 | Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression | View | |
| NCT06085950 | Transcranial Ultrasonic Stimulation in Treatment-resistant Depression an Open-label Pilot Trial | View | |
| NCT06096207 | DBS for Depression | View | |
| NCT01162434 | Brain MRI Magnetic Resonance Imaging Scans of Patients With Treatment Resistant Depression TRD and Healthy Controls | View | |
| NCT06138691 | KET-RO Plus RO DBT for Treatment Resistant Depression | View | |
| NCT06172413 | Transcranial Alternating Current Stimulation for Treatment-Resistant Depression | View | |
| NCT06236711 | Transcranial Direct Current Stimulation tDCS As an Adjunctive Treatment for Treatment Resistant Depression TRD | View | |
| NCT06278779 | Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression | View | |
| NCT06303739 | Psilocybin-Assisted Therapy in Treatment-Resistant Depression | View | |
| NCT06372834 | Adjuvant Accelerated piTBS for Reducing Suicidal Ideation in TRD Patients | View | |
| NCT06488586 | IV Ketamine Vs in Esketamine for MDD TRD | View | |
| NCT06480201 | Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression | View | |
| NCT05454410 | Study of Efficacy Safety Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression TRD | View | |
| NCT00690768 | Pars Plana Vitrectomy PPV Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment IBETRA | View | |
| NCT05415826 | Ozurdex in Reducing PVR After Vitreotomy in PDR | View | |
| NCT03932825 | Nitrous Oxide for Major Depressive Disorder | View | |
| NCT02141776 | Comparison of Anodal Transcranial Direct Current Stimulation t-DCS and Sham Stimulation in Patients With Treatment-resistant Depression | View | |
| NCT05438758 | Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study | View | |
| NCT02830399 | Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression | View | |
| NCT04080778 | Magnetic Seizure Therapy in Bipolar Depression MST-BpD and Treatment Resistant Depression MST-TRD | View | |
| NCT02219867 | Ketamine Infusions for Major Depression Disorder | View | |
| NCT02253355 | PINS Stimulator System for Patients With Treatment Resistant Depression | View | |
| NCT05537558 | Precision Medicine for the Prediction of Treatment PROMPT Response PROMPT | View | |
| NCT05554627 | VA Aripiprazole vs Esketamine for Treatment Resistant Depression | View | |
| NCT00320372 | Treatment-Resistant Depression Registry | View | |
| NCT00174876 | Aripiprazole as Augmentation for TRD | View | |
| NCT02418585 | A Study to Evaluate the Efficacy Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression | View | |
| NCT02422186 | A Study to Evaluate the Efficacy Safety and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression | View | |
| NCT02493868 | A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression | View | |
| NCT02559466 | Efficacy of Deep Transcranial Magnetic Stimulation TMS for Treatment-resistant Depression and Neuroanatomical Correlates a Clinical Study Coupled With Positon Emission Tomography PET | View | |
| NCT02729792 | Canadian rTMS Treatment and Biomarker Network in Depression Trial | View | |
| NCT02911597 | Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression TRD | View | |
| NCT03254017 | Remotely Programmed Deep Brain Stimulation of the Bilateral Habenula for Treatment- Resistant Major Depression An Open Label Pilot Trial | View | |
| NCT03329391 | Psychosocial Characteristics and Non-pharmacological Intervention of Patients With Treatment-resistant Depression | View | |
| NCT03347487 | DBS of the Habenula for Treatment- Resistant Major Depression | View | |
| NCT03642522 | Investigating Predictors of Treatment Response in Treatment-Resistant Depression TRD With Interleaved TMSfMRI | View | |
| NCT03701724 | Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression | View | |
| NCT03986658 | Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression Tolerability of Treatment Durations Ranging From Ten Days to One Day | View | |
| NCT04078438 | Neurofeedback In Treatment Resistant Depression | View |